Abstract
Purpose
To evaluate the effectiveness and safety of oral supplementation as a radioprotective intervention in the management of radiation dermatitis (RD).
Methods
Systematic review and meta-analysis. Six databases and the gray literature were searched for randomized controlled clinical trials (RCTs). Meta-analysis was performed only with studies that evaluated the same intervention. Methodology of included studies was evaluated by the Cochrane risk-of-bias tool for randomized trials (RoB 2.0), and the certainty of evidence was assessed by the GRADE instrument.
Results
Seventeen RCTs were included in this review. These evaluated different types of oral supplementations. Findings from three meta-analyses demonstrated no significant benefits to the more severe grades of RD, as oral curcuminoids (RR, 0.59; 95% CI, 0.27 to 1.29; P = 0.19; I2 = 88%), glutamine (RR, 0.40; 95% CI, 0.15 to 1.03; P = 0.06; I2 = 78%) or Wobe-Mugos (RR, 0.57; 95% CI, 0.29 to 1.14; P = 0.11; I2 = 72%). Also, the certainty of the evidence of outcomes evaluated was moderate or low. Except for a few gastrointestinal adverse events, oral supplementation was well tolerated.
Conclusion
Most oral supplements cannot yet be recommended to manage RD due to insufficient or conflicting evidence. However, despite no significant results, glutamine was shown to be a promising substance in terms of the potential radioprotective effect and may be well tolerated. These results suggest that more RCTs with larger samples are needed to evaluate the efficacy, safety, and tolerance of glutamine in the management of RD.
Similar content being viewed by others
Data Availability
Not applicable.
References
Robijns J, Laubach HJ (2018) Acute and chronic radiodermatitis: clinical signs, pathophysiology, risk factors, and management options. J Egyptian Women’s Dermatol Soc 15(1):2–9. https://doi.org/10.1097/01.EWX.0000529960.52517.4c
Seité S, Bensadoun RJ, Mazer JM (2017) Prevention and treatment of acute and chronic radiodermatitis. Breast Cancer (Dove Med Press) 9(1):551–557. https://doi.org/10.2147/bctt.s149752
Iacovelli NA, Galaverni M, Cavallo A et al (2018) Prevention and treatment of radiation-induced acute dermatitis in head and neck cancer patients: a systematic review. Future Oncol 14(3):291–305. https://doi.org/10.2217/fon-2017-0359
Robijns J, Censabella S, Claes S et al (2018) Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial). Lasers Surg Med 50(7):763–771. https://doi.org/10.1002/lsm.22804
Partl R, Jonko B, Schnidar S et al (2017) 128 SHADES OF RED: objective remote assessment of radiation dermatitis by augmented digital skin imaging. Health Inform Meets 236:363–374. https://ebooks.iospress.nl/publication/46500. Accessed 15 Aug 2022
Bontempo PSM, Ciol MA, Menêses AG et al (2021) Acute radiodermatitis in cancer patients: incidence and severity estimates. Rev Esc Enferm USP 55(1):e03676. https://doi.org/10.1590/S1980-220X2019021703676
Kole AJ, Kole L, Moran M (2017) Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer (Dove Med Press) 9(1):313–323. https://doi.org/10.2147/bctt.s109763
Leventhal J, Young MR (2017) Radiation dermatitis: recognition, prevention, and management. Oncology. 29;31(12):885–7. https://www.cancernetwork.com/view/radiation-dermatitis-recognition-prevention-and-management. Accessed 10 Oct 2022
Zhao H, Zhu W, Zhao X et al (2022) Efficacy of Epigallocatechin-3-Gallate in preventing dermatitis in patients with breast cancer receiving postoperative radiotherapy a double-blind, Placebo-Controlled, Phase 2 randomized clinical trial. JAMA Dermatol 158(7):779–786. https://doi.org/10.1001/jamadermatol.2022.1736
Yee C, Wang K, Asthana R et al (2018) Radiation-induced skin toxicity in breast cancer patients: a systematic review of randomized trials. Clin Breast Cancer 18(5):e825–e840. https://doi.org/10.1016/j.clbc.2018.06.015
Ryan WJ, Heckler CE, Guido JJ et al (2017) Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients. Support Care Cancer 26(5):1543–1552. https://doi.org/10.1007/s00520-017-3957-4
Sekiguchi K, Akahane K, Ogita M et al (2018) Efficacy of heparinoid moisturizer as a prophylactic agent for radiation dermatitis following radiotherapy after breast-conserving surgery: a randomized controlled trial. Jpn J Clin Oncol 48(5):450–457. https://doi.org/10.1093/jjco/hyy045
Imai T, Matsuura K, Asada Y et al (2014) Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy. Jpn J Clin Oncol 44(5):422–427. https://doi.org/10.1093/jjco/hyu027
Menêses AG, Normando AGC, Porto TI et al (2019) Effects of oral supplementation in the management of oral mucositis in cancer patients: A meta-analysis of randomized clinical trials. J Oral Pathol Med 9(2):117–125. https://doi.org/10.1111/jop
Lopez-Vaquero D, Gutierrez-Bayard L, Rodriguez-Ruiz JA et al (2017) Double-blind randomized study of oral glutamine on the management of radio/chemotherapy-induced mucositis and dermatitis in head and neck cancer. Mol Clin Oncol 6(6):931–936. https://doi.org/10.3892/mco.2017.1238
Huang CJ, Huang MY, Fang PT et al (2019) Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients. Am J Clin Nutr 109(3):606–614. https://doi.org/10.1093/ajcn/nqy329
Bracone F, De Curtis A, Castelnuovo Di et al (2021) Skin toxicity following radiotherapy in patients with breast carcinoma: is anthocyanin supplementation beneficial? Clin Nutr 40(4):2068–2077. https://doi.org/10.1016/j.clnu.2020.09.030
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372(7). https://doi.org/10.1136/bmj.n71
Vasconcelos SCMV, Ribeiro LS, Guerra ENS et al (2022) Effects of oral supplementation to manage radiation dermatitis in cancer patients: a systematic review. PROSPERO, CRD42022330404. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022330404. Accessed 05 Apr 2022
Ouzzani M, Hammady H, Fedorowicz Z et al (2016) Rayyan ‐ a web and mobile app for systematic reviews. Systematic Reviews. https://rayyan.qcri.org/. Accessed 20 Apr 2022
Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366(1):l4898. https://doi.org/10.1136/bmj.l4898
RevMan [Internet]. training.cochrane.org. Available from: https://training.cochrane.org/online-learning/core-software/revman. Accessed Dec 2022
Murad MH, Mustafa RA, Schunemann HJ et al (2017) Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med 22(3):85–87. https://doi.org/10.1136/ebmed-2017-110668
Schünemann H, Brożek J, Guyatt G et al (2013) GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. Available from: https://www.guidelinedevelopment.org/handbook. Accessed 25 Apr 2022
McMaster University GRADEpro Guideline Development Tool [Software]. Inc. GRADEpro GDT 2015
Aygenc E, Celikkanat S, Kaymakci M et al (2004) Prophylactic effect of pentoxifylline on radiotherapy complications: a clinical study. Otolaryngol Head Neck Surg 130(3):351–356. https://doi.org/10.1016/j.otohns.2003.08.015
Bairati I, Meyer F, Gélinas M et al (2005) Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 23(24):5805–5813. https://doi.org/10.1200/jco.2005.05.514
Gujral MS, Patnaik PM, Kaul R et al (2001) Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers. Cancer Chemother Pharmacol 47:S23–S28. https://doi.org/10.1007/s002800170005
Huang S, Piao Y, Cao C et al (2020) A prospective randomized controlled trial on the value of prophylactic oral nutritional supplementation in locally advanced nasopharyngeal carcinoma patients receiving chemo-radiotherapy. Oral Oncol 111(1):105025. https://doi.org/10.1016/j.oraloncology.2020.105025
Lievens Y, Haustermans K, Van den Weyngaert D et al (1998) Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiol Oncol 47(2):149–153. https://doi.org/10.1016/s0167-8140(97)00231-4
Lin LC, Que J, Lin LK et al (2006) Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: A double-blind, randomized study. Int J Radiat Oncol Biol Phys 65(3):745–750. https://doi.org/10.1016/j.ijrobp.2006.01.015
Eda K, Uzer K, Murat T et al (2016) The effects of enteral glutamine on radiotherapy induced dermatitis in breast cancer. Clin Nutr 35(2):436–439. https://doi.org/10.1016/j.clnu.2015.03.009
Huang CJ, Hou MF, Kan JY et al (2015) Prophylactic treatment with Adlay Bran extract reduces the risk of severe acute radiation dermatitis: A prospective, randomized, double-blind study. Evid Based Complement Alternat Med: 1–8. https://doi.org/10.1155/2015/312072
Ryan JL, Heckler CE, Ling M et al (2013) Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. J Radiat Res 180(1):34–43. https://doi.org/10.1667/RR3255.1
Talakesh T, Tabatabaee N, Atoof F et al (2022) Effect of nano-curcumin on radiotherapy-induced skin reaction in breast cancer patients: A randomized, triple-blind, placebo-controlled trial. Curr Radiopharm 15(4):332–340. https://doi.org/10.2174/1874471015666220623104316
Dale PS, Tamhankar CP, George D et al (2001) Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother Pharmacol 47:S29–S34. https://doi.org/10.1007/s002800170006
Martin T, Uhder K, Kurek R et al (2002) Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial. Radiother Oncol 65(1):17–22. https://doi.org/10.1016/s0167-8140(02)00192-5
Normando AGC, Menêses AG, Toledo IP et al (2019) Effects of turmeric and curcumin on oral mucositis: A systematic review. Phytother Res 33(5):1318–1329. https://doi.org/10.1002/ptr.6326
Kia JS, Basirat M, Saedi HS et al (2021) Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucositis in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial. BMC Complement Med Ther 21(1):232. https://doi.org/10.1186/s12906-021-03400-4
Modaresi M, Harfbol M, Ahmadi F (2017) A review on pharmacological effects and therapeutic properties of curcumin. J Med Plants 16(62):1–17. Available from: http://jmp.ir/article-1-1451-en.html. Accessed Dec 2022
Vaughn AR, Branum A, Sivamani RK (2016) Effects of turmeric (Curcuma longa) on skin health: A systematic review of the clinical evidence. Phytother Res 30(8):1243–1264. https://doi.org/10.1002/ptr.5640
Okunieff P, Xu J, Hu D et al (2006) Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 65(3):890–898. https://doi.org/10.1016/j.ijrobp.2006.03.025
Palatty PL, Azmidah A, Rao S et al (2014) Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: A pilot study. Br J Radiol 87(1038):20130490. https://doi.org/10.1259/bjr.20130490
Dharman SGM, Shanmugasundaram K, Sampath RK (2021) A systematic review and meta-analysis on the efficacy of curcumin/turmeric for the prevention and amelioration of radiotherapy/radiochemotherapy induced oral mucositis in head and neck cancer patients. Asian Pac J Cancer Prev 22(6):1671–1684. https://doi.org/10.31557/apjcp.2021.22.6.1671
Alsubaie HM, Alsini AY, Alsubaie KM et al (2021) Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: A systematic review and meta-analysis of controlled trials. Head Neck 43(10):3199–3213. https://doi.org/10.1002/hed.26798
Anderson PM, Lalla RV (2020) Glutamine for amelioration of radiation and chemotherapy associated mucositis during cancer therapy. Nutrients 12(6):1675. https://doi.org/10.3390/nu12061675
Karna E, Miltyk W, Wolczynski S et al (2001) The potential mechanism for glutamine-induced collagen biosynthesis in cultured human skin fibroblasts. Comp Biochem Physiol B Biochem Mol Biol 130(1):23–32. https://doi.org/10.1016/s1096-4959(01)00400-6
Leung HWC, Chan ALF (2016) Glutamine in alleviation of radiation-induced severe oral mucositis: A meta-analysis. Nutr Cancer 68(5):734–742. https://doi.org/10.1080/01635581.2016.1159700
Wolfgang D, Herrmann T (2007) Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy: results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study. Strahlenther Onkol 183(3):121–127. https://doi.org/10.1007/s00066-007-1634-0
Dörr W, Herrmann T (2007) Efficacy of Wobe-Mugos® E for reduction of oral mucositis after radiotherapy. Strahlenther Onkol 183(3):121–127. https://doi.org/10.1007/s00066-007-1634-0
Chan RJ, Webster J, Chung B et al (2014) Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer 14:53. https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-53. Accessed 05 Oct 2022
Bontempo PSM, Menêses AG, Ferreira EB et al (2022) Escalas para mensurar radiodermatite aguda: vantagens e desvantagens. Conjecturas 22(16):84–103. https://doi.org/10.53660/CONJ-1981-2R63A
González-Sanchís A, Vicedo-Gonzáles A, Brualla-González L et al (2014) Looking for complementary alternatives to CTCAE for skin toxicity in radiotherapy: quantitative determinations. Clin Transl Oncol 16(1):892–897. https://doi.org/10.1007/s12094-014-1163-0
Funding
The first author received financial support for the research in the Nursing Graduate Program at the University of Brasília, Brazil. The Program had no role in the study design and interpretation of results. This research did not receive funding from agencies.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by S.C.C.M.V, E.B.F., A.G.M., E.N.S.G. and P.E.D.R. The first draft of the manuscript was written by S.C.C.M.V and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
This is a systematic review; no ethical approval is required.
Consent to participate
This is a systematic review; no informed consent is required.
Consent to publish
This is a systematic review, with no human research participants.
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
e Vasconcelos, S.C.C.M., Guerra, E.N.S., de Menêses, A.G. et al. Effects of oral supplementation to manage radiation dermatitis in cancer patients: a systematic review. Support Care Cancer 31, 240 (2023). https://doi.org/10.1007/s00520-023-07685-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00520-023-07685-8